New blood biomarkers reveal how common muscular dystrophy treatment may impair overall growth

In a study published in Scientific Reports, an international, multidisciplinary research team that included Binghamton University researchers identified a set of blood proteins that may explain why the corticosteroid prednisone, although beneficial in treating Duchenne muscular dystrophy (DMD), can interfere with childhood growth and bone health.

Read it at Medical Xpress ↗

← Front page